Probiotics, live microorganisms providing health benefits when consumed, and prebiotics, non-digestible fibers fostering beneficial gut bacteria, form a synergistic duo in therapy. Probiotics aid in restoring gut microbiota balance, enhancing immune function, and mitigating gastrointestinal disorders like irritable bowel syndrome and inflammatory bowel disease. Prebiotics, by nourishing beneficial bacteria, amplify probiotic efficacy, fostering a resilient gut environment. Together, they modulate gut-brain communication, potentially alleviating mental health issues like anxiety and depression. Emerging research highlights their role in metabolic health, showing promise in managing conditions like obesity and diabetes. This combined approach, leveraging probiotics and prebiotics, exemplifies a holistic strategy in therapeutic interventions, promoting overall well-being.
Title : Results from a cross-sectional observational study examining irritable bowel syndrome patients six months after finishing their participation in the ViIBS trial
Jacek Piatek, Calisia University, Poland
Title : Gut microbiome as a driver of healthy ageing
Thi Thu Hao Van, RMIT University, Australia
Title : Treating irritable bowel syndrome patients with a balanced multi-strain synbiotic–results from a multi-center, randomized, double-blind, placebo-controlled clinical trial (the ViIBS trial)
Henning Sommermeyer, Calisia University, Poland
Title : Molecular mechanisms underlying the anti-atherogenic actions of probiotics
Dipak P Ramji, Cardiff University, United Kingdom
Title : Global regulatory trends on the use of probiotics and prebiotics in foods and food supplements
David Pineda Ereno, DPE International Consulting, Belgium
Title : Biochemical profile and nutripotential glimpses of Terminalia arjuna bark extract
Suriyavathana Muthukrishnan, Periyar University, India